GO:0000297 spermine transmembrane transporter activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0000297 (spermine transmembrane transporter activity) is a molecular function that enables the transfer of spermine across a membrane.
• Spermine is a polybasic amine involved in nucleic acid packaging, and its synthesis is regulated by ornithine decarboxylase, which plays a key role in DNA replication control.
• Spermine transport has been characterized in prokaryotes and eukaryotes, including mitochondria and erythrocytes [2,3,4].
• Spermine directly interacts with ion channels such as inwardly rectifying potassium channels and modulates NMDA and AMPA receptors [6,7,8].
• P5B-ATPases are structurally related to spermine transport mechanisms and provide a framework for understanding polyamine translocation.
• Dysregulation of spermine transport is implicated in cancer, neurodegeneration, and cardiovascular disorders, making it a target for CRISPR-based functional studies [2,4,7].
Description
Spermine transmembrane transporter activity (GO:0000297) is a molecular function that enables the movement of spermine, a polybasic amine, from one side of a membrane to the other. Spermine is found in human sperm, ribosomes, and some viruses, where it is involved in nucleic acid packaging. Its synthesis is regulated by ornithine decarboxylase, an enzyme that plays a key role in the control of DNA replication. This transport activity is essential for maintaining cellular polyamine homeostasis and for diverse physiological processes, including ion channel modulation and mitochondrial function [4,6]. Researchers study spermine transmembrane transporter activity to understand how polyamines influence membrane dynamics, ion channel gating, and cellular signaling [3,5,6]. The transport of spermine across membranes has been demonstrated in various systems, including rat heart mitochondria and erythrocytes, where it affects phospholipid redistribution and mitochondrial function [3,4]. In prokaryotes and eukaryotes, polyamine transport systems are critical for growth, stress responses, and virulence. Given its broad impact, spermine transmembrane transporter activity is a subject of intense investigation in cancer biology, neuroscience, and cardiovascular research [2,7,8]. The development of CRISPR-based models has enabled precise interrogation of the genes and pathways that regulate spermine transport, offering new opportunities for therapeutic targeting [1,2].
spermine transmembrane transporter activity At A Glance
| GO ID | GO:0000297 |
|---|---|
| GO term | spermine transmembrane transporter activity |
| Ontology | molecular_function |
| Synonym | None |
| Major function | Enables the transfer of spermine across a membrane |
| Substrate | Spermine (polybasic amine) |
| Biological context | Polyamine homeostasis, nucleic acid packaging, ion channel modulation |
| Related processes | Mitochondrial transport, phospholipid redistribution, receptor regulation |
What Is GO:0000297?
Spermine transmembrane transporter activity (GO:0000297) is defined as the molecular function that enables the transfer of spermine from one side of a membrane to the other. Spermine is a polybasic amine found in human sperm, ribosomes, and some viruses, where it participates in nucleic acid packaging. Its synthesis is regulated by ornithine decarboxylase, which is key in controlling DNA replication. This activity is classified under the molecular_function ontology aspect.
Why Is spermine transmembrane transporter activity Important in Cell Biology?
Spermine transmembrane transporter activity is critical for maintaining cellular polyamine levels, which influence nucleic acid stability, ion channel function, and mitochondrial metabolism [2,4,6]. Dysregulation of spermine transport has been linked to cancer progression, neurodegeneration, and cardiovascular disorders, making it a promising target for therapeutic intervention [2,7,8]. Understanding this activity at the molecular level can reveal new strategies for modulating polyamine-dependent processes in health and disease.
• Regulates intracellular polyamine homeostasis, affecting cell growth and differentiation.
• Modulates ion channels, including inwardly rectifying potassium channels and NMDA/AMPA receptors [6,7,8].
• Influences mitochondrial function and energy metabolism.
• Plays a role in phospholipid transmembrane redistribution in erythrocytes.
• Implicated in cancer cell proliferation and survival.
• Contributes to neuronal excitability and synaptic plasticity [7,8].
• Potential target for anti-cancer and neuroprotective therapies [2,7].
• Essential for nucleic acid packaging in viruses and sperm.
• Provides a model for studying polyamine transport in prokaryotes and eukaryotes.
• Enables CRISPR-based functional genomics of polyamine transporters.
What Happens During spermine transmembrane transporter activity?
Substrate recognition and binding
In simple terms: The transporter first recognizes and binds spermine on one side of the membrane.
Spermine, a polybasic amine, is recognized by specific binding sites within the transporter protein. This interaction is driven by electrostatic forces between the positively charged spermine molecule and negatively charged residues in the transporter. In mitochondria, spermine transport is linked to membrane potential and phospholipid interactions. The binding step ensures selectivity for spermine over other polyamines.
Translocation across the membrane
In simple terms: The transporter then moves spermine through the membrane to the other side.
Following binding, the transporter undergoes conformational changes that allow spermine to pass through the membrane. This process may involve a channel-like or carrier-like mechanism, as seen in P5B-ATPases, which are structurally related to polyamine transporters. In erythrocytes, spermine translocation is coupled to phosphatidylinositol 4,5-bisphosphate-mediated phospholipid redistribution. The translocation step is energy-dependent in some systems, particularly in mitochondria.
Release and cellular effects
In simple terms: Once across, spermine is released to exert its effects inside the cell or organelle.
After translocation, spermine is released into the target compartment, where it can interact with nucleic acids, ion channels, and other proteins. For example, spermine directly interacts with inwardly rectifying potassium channels, modulating their activity. It also blocks or stimulates NMDA and AMPA receptors, influencing neuronal signaling [7,8]. These downstream effects underscore the physiological importance of spermine transport.
Regulation of transport activity
In simple terms: The transport process is regulated to meet cellular needs.
Spermine transport activity is regulated by factors such as membrane potential, calcium ions, and the availability of spermine [3,4]. In mitochondria, transport is influenced by the electrochemical gradient. In erythrocytes, calcium and spermine antagonistically affect phospholipid redistribution, suggesting a regulatory interplay. Additionally, the expression and activity of transporters can be modulated by cellular signals, though specific pathways require further study.
Key Genes Involved in GO:0000297 spermine transmembrane transporter activity
The following genes and proteins are directly or indirectly involved in spermine transmembrane transporter activity and its regulation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ATP13A2 | P5B-ATPase involved in polyamine transport | Mutations linked to neurodegeneration; model for transport studies |
| ATP13A3 | P5B-ATPase, putative polyamine transporter | Role in cancer and cardiovascular disease |
| ATP13A4 | P5B-ATPase, candidate polyamine transporter | Potential involvement in neurodevelopment |
| ATP13A5 | P5B-ATPase, polyamine transport | Understudied; potential metabolic role |
| KCNJ2 | Inwardly rectifying potassium channel | Directly interacts with spermine; modulates channel activity |
| KCNJ4 | Inwardly rectifying potassium channel | Spermine-sensitive; involved in neuronal signaling |
| GRIN1 | NMDA receptor subunit | Spermine modulates receptor function via pore region |
| GRIN2A | NMDA receptor subunit | Spermine block/stimulation depends on subunit composition |
| GRIN2B | NMDA receptor subunit | Spermine sensitivity influenced by subunit |
| GRIA1 | AMPA receptor subunit | Spermine block attenuated by stargazin |
| GRIA2 | AMPA receptor subunit | Calcium permeability and polyamine block |
| CACNG2 | Stargazin, AMPA receptor auxiliary subunit | Regulates polyamine block of AMPA receptors |
| ODC1 | Ornithine decarboxylase, spermine synthesis | Key regulator of polyamine levels and DNA replication |
| SAT1 | Spermidine/spermine N1-acetyltransferase | Catabolizes spermine; affects transport demand |
| SLC3A2 | Polyamine transport component | Involved in polyamine uptake in eukaryotes |
| SLC7A1 | Cationic amino acid transporter | May contribute to polyamine transport |
| TRPM4 | Calcium-activated cation channel | Spermine modulates selectivity filter |
How Is spermine transmembrane transporter activity Regulated?
Spermine transmembrane transporter activity is regulated at multiple levels. The synthesis of spermine is controlled by ornithine decarboxylase (ODC1), which is a key regulator of polyamine levels and DNA replication. Transport activity itself can be modulated by membrane potential, calcium ions, and the availability of spermine [3,4]. In mitochondria, the electrochemical gradient drives spermine uptake. In erythrocytes, calcium and spermine exert antagonistic effects on phospholipid redistribution, indicating a regulatory interplay. Additionally, the expression and activity of transporters such as P5B-ATPases may be influenced by cellular stress and signaling pathways, though specific mechanisms require further investigation.
spermine transmembrane transporter activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ATP13A2 | Kufor-Rakeb syndrome, Parkinson's disease | Knockout and point-mutation iPSC-derived neurons |
| ATP13A3 | Cancer, cardiovascular disease | Overexpression and knockout cancer cell lines |
| GRIN1 | Neurodegeneration, excitotoxicity | Point-mutation knock-in mice |
| GRIA1 | Epilepsy, synaptic plasticity | Knockout and knock-in rodent models |
| KCNJ2 | Andersen-Tawil syndrome, arrhythmia | Knock-in cell models for channelopathy |
Cancer
Altered polyamine transport and spermine levels are frequently observed in cancer cells, where they support rapid proliferation and survival. Targeting spermine transmembrane transporter activity could disrupt polyamine homeostasis and inhibit tumor growth. For example, P5B-ATPases such as ATP13A2 and ATP13A3 are implicated in cancer cell metabolism and drug resistance. Understanding these transport mechanisms may lead to novel anticancer strategies.
Neurodegeneration
Spermine modulates NMDA and AMPA receptors, which are critical for synaptic plasticity and excitotoxicity [7,8]. Dysregulation of spermine transport may contribute to neurodegenerative disorders such as Alzheimer's and Parkinson's diseases. Mutations in ATP13A2, a polyamine transporter, are linked to Kufor-Rakeb syndrome, a form of early-onset parkinsonism. Thus, spermine transport is a potential therapeutic target for neuroprotection.
Cardiovascular disorders
Spermine affects ion channels and mitochondrial function in cardiac tissue [4,6]. In rat heart mitochondria, spermine transport influences energy metabolism and calcium handling. Dysregulation of spermine transport may contribute to cardiac arrhythmias and ischemia-reperfusion injury. Further research is needed to elucidate the role of specific transporters in cardiovascular disease.
From spermine transmembrane transporter activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of ATP13A2 affect spermine transport? | ATP13A2 knockout cell line (e.g., HEK293 or iPSC-derived neurons) |
| How does a disease-associated mutation alter transport? | Point-mutation knock-in of ATP13A2 (e.g., G504R) |
| Can we visualize spermine transporter localization? | Tagged knock-in of ATP13A2 with fluorescent protein |
| Does overexpression of ATP13A3 increase spermine uptake? | ATP13A3 overexpression in cancer cell lines |
| What genes regulate spermine transport? | CRISPR library screening in polyamine-sensitive cells |
| How does spermine affect ion channel function? | Knockout of KCNJ2 or GRIN1 in neuronal cultures |
How to Study the spermine transmembrane transporter activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radiolabeled spermine uptake | Transport rate and capacity | Characterization of transporter activity in cells |
| Patch-clamp electrophysiology | Ion channel modulation by spermine | Study of K+ and NMDA/AMPA receptor function |
| CRISPR knockout screening | Genes affecting spermine sensitivity | Identification of novel transport regulators |
| Cryo-EM | Three-dimensional structure of transporters | Mechanistic understanding of P5B-ATPases |
| Fluorescent spermine imaging | Intracellular spermine distribution | Live-cell tracking of transport dynamics |
| RNA-seq | Transcriptional changes upon transport modulation | Pathway analysis in knockout models |
| Proteomics | Protein interactions with transporters | Identification of transport complexes |
Transport assays
Radiolabeled spermine uptake assays are used to measure transport activity in cells and isolated organelles [2,4]. These assays can be combined with membrane fractionation to determine subcellular localization. For real-time monitoring, fluorescent spermine analogs are available.
Electrophysiology
Patch-clamp recordings assess the effect of spermine on ion channels such as inwardly rectifying potassium channels and NMDA receptors [6,7]. This method reveals direct modulation of channel activity by spermine and can be applied to cells expressing wild-type or mutant transporters.
CRISPR screening
Genome-wide CRISPR knockout or activation screens can identify genes that regulate spermine transport and sensitivity. Libraries targeting transporters, channels, and metabolic enzymes are particularly useful. Hits are validated by individual knockout or overexpression.
Structural biology
Cryo-EM and X-ray crystallography of P5B-ATPases provide insights into the molecular mechanism of spermine transport. These structures guide mutagenesis studies to test functional hypotheses.
How CRISPR Can Be Used to Study GO:0000297 spermine transmembrane transporter activity
Knockout
CRISPR knockout of candidate genes such as ATP13A2 or KCNJ2 enables loss-of-function studies to determine their role in spermine transport and downstream signaling [1,6]. Knockout cell lines can be used for transport assays, electrophysiology, and phenotypic screens.
Point Mutation
Introducing disease-associated point mutations (e.g., ATP13A2 G504R) via CRISPR knock-in allows precise modeling of transport defects. These models are valuable for testing pharmacological chaperones or correcting transport activity.
Knock-in
Tagged knock-in of transporters with fluorescent or affinity tags facilitates localization and interaction studies. This approach preserves endogenous regulation and can be combined with live-cell imaging.
Overexpression
CRISPR activation or cDNA overexpression of genes like ATP13A3 increases spermine transport capacity, useful for gain-of-function studies and drug screening [1,2]. Overexpression models help identify downstream effects of enhanced polyamine uptake.
How EDITGENE Supports spermine transmembrane transporter activity Research
Researchers studying spermine transmembrane transporter activity-related genes often need to determine whether a candidate gene is causally involved in polyamine transport, ion channel modulation, or disease phenotypes. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from gene knockout to precise point mutations and library screening.
Contact EDITGENE today to design your custom CRISPR model for spermine transmembrane transporter activity research.
Frequently Asked Questions About spermine transmembrane transporter activity
What is spermine transmembrane transporter activity?
It is a molecular function (GO:0000297) that enables the transfer of spermine across a membrane, as defined by QuickGO.
What genes are involved in spermine transmembrane transporter activity?
Genes include ATP13A2-5 (P5B-ATPases), KCNJ2, GRIN1, GRIA1, and ODC1, among others [1,2,6,7,8].
How is spermine transported across membranes?
Spermine transport involves substrate recognition, translocation, and release, often driven by membrane potential or electrochemical gradients [2,4].
What diseases are associated with spermine transport?
Dysregulation is linked to cancer, neurodegeneration (e.g., Kufor-Rakeb syndrome), and cardiovascular disorders [1,2,7].
How can I study spermine transmembrane transporter activity?
Use radiolabeled uptake assays, electrophysiology, CRISPR screening, and structural biology [1,2,6].
What are P5B-ATPases?
P5B-ATPases are a subfamily of ATPases involved in polyamine transport, with structural similarities to spermine transporters.
Does spermine interact with ion channels?
Yes, spermine directly interacts with inwardly rectifying potassium channels and modulates NMDA and AMPA receptors [6,7,8].
What is the role of ornithine decarboxylase in spermine transport?
Ornithine decarboxylase regulates spermine synthesis, which in turn affects transport demand and cellular polyamine levels.
Can CRISPR be used to study spermine transport?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable precise functional studies.
What model systems are available for spermine transport research?
Common models include HEK293 cells, iPSC-derived neurons, and rodent mitochondria [1,4,6].
Conclusion
Spermine transmembrane transporter activity (GO:0000297) is a fundamental molecular function that governs polyamine homeostasis and influences diverse cellular processes, from ion channel modulation to mitochondrial metabolism [2,4,6]. Its dysregulation is implicated in cancer, neurodegeneration, and cardiovascular disease, highlighting its therapeutic potential [1,2,7]. Advances in CRISPR-based models and structural biology are accelerating our understanding of spermine transport mechanisms. EDITGENE's comprehensive services empower researchers to dissect the genes and pathways involved, paving the way for novel interventions.
References
- 1. Li P et al.. 2021. Structure and transport mechanism of P5B-ATPases.. Nat Commun 12(1):3973 PMID: 34172751
- 2. Igarashi K et al.. 2010. Characteristics of cellular polyamine transport in prokaryotes and eukaryotes.. Plant Physiol Biochem 48(7):506-12 PMID: 20159658
- 3. Sulpice JC et al.. 1996. Antagonist effects of Ca2+ and spermine on phosphatidylinositol 4,5-bisphosphate-mediated transmembrane redistribution of phospholipids in large unilamellar vesicles and in erythrocytes.. Biochemistry 35(41):13345-52 PMID: 8873601
- 4. Toninello A et al.. 1990. Transport and action of spermine in rat heart mitochondria.. Cardioscience 1(4):287-94 PMID: 2104195
- 5. Nilius B et al.. 2005. The selectivity filter of the cation channel TRPM4.. J Biol Chem 280(24):22899-906 PMID: 15845551
- 6. Osawa M et al.. 2009. Evidence for the direct interaction of spermine with the inwardly rectifying potassium channel.. J Biol Chem 284(38):26117-26 PMID: 19620244
- 7. Jin L et al.. 2008. The pore region of N-methyl-D-aspartate receptors differentially influences stimulation and block by spermine.. J Pharmacol Exp Ther 327(1):68-77 PMID: 18632991
- 8. Soto D et al.. 2007. Stargazin attenuates intracellular polyamine block of calcium-permeable AMPA receptors.. Nat Neurosci 10(10):1260-7 PMID: 17873873
